Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 457 followers
Latest posts
Last updated 3 days ago
GSK to become a founding partner of Fleming Initiative to fight antimicrobial resistance (AMR)
2 days ago
GSK pledges to support the Fleming Initiative - an innovative and collaborative...
GSK makes a strong start to 2024 with improving outlook for the year
17 days ago
Q1 2024 performance highlights
US FDA accepts for priority review GSK’s application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
24 days ago
Application supported by statistically significant and clinically meaningful progression-free and overall survival...
US FDA accepts for priority review GSK’s application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
24 days ago
Application supported by statistically significant and clinically meaningful progression-free and overall survival...
New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade
about 1 month ago
End-of-trial data show 79.7% efficacy in participants aged 50 years and over...
EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments
about 1 month ago
GSK has announced positive results from the pivotal EAGLE-1 phase III trial...
GSK’s 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA
about 1 month ago
Prescription Drug User Fee Act action date set by FDA for 14...
Positive RUBY phase III data show potential for Jemperli (dostarlimab) combinations in more patients with primary advanced or recurrent endometrial cancer
2 months ago
Only immuno-oncology combination to show statistically significant and clinically meaningful overall survival...
GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myeloma
2 months ago
Trial unblinded early at an interim analysis based on Independent Data Monitoring...
ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) compared to daily oral therapy in individuals living with HIV who have adherence challenges
2 months ago
The data were presented by the Advancing Clinical Therapeutics Globally for HIV/AIDS...
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
2 months ago
GSK announced the company’s first step towards delivering ultra long-acting injectable HIV...
GSK announces Dr Jeannie Lee to join the Board as Non-Executive Director
3 months ago
GSK plc (LSE/NYSE: GSK) has today announced that Dr Jeannie Lee has...